2010-11-19 00:00:00,Takeda Pharmaceutical Company Limited and Johnson Johnson Recall Batches of Cancer Drug
2010-11-23 00:00:00,Johnson Johnson Recalls 4 Million Packages Of
2010-11-24 00:00:00,Johnson Johnson Recalls More Cites Label
2010-11-29 00:00:00,Tribunal Finds Johnson Johnson In Breach Of License Agreement With Basilea Pharmaceutica AG
2010-12-01 00:00:00,Johnson Janssen Pharmaceutica Announces Collaboration to Develop Diagnostic Biosignatures for Identification of Disease
2010-12-06 00:00:00,Lawsuits Against Johnson Johnson Involving Defective DePuy Hip Replacement Parts To Be consolidated In Multidistrict Litigation
2010-12-08 00:00:00,Jury Rules Against Johnson Johnson In Antibiotic
2010-12-13 00:00:00,DePuy Hip Replacement Class Action Commenced by Stevensons LLP Against Johnson Johnson
2010-12-23 00:00:00,Johnson Janssen Announces New Drug Submission For Abiraterone Acetate For The Treatment Of Metastatic Advanced Prostate Cancer
2010-12-28 00:00:00,FDA Places Johnson Johnson Pain Drug On Clinical
2011-01-25 00:00:00,Johnson Johnson Issues FY 2011 EPS Guidance Below Estimates
2011-01-28 00:00:00,Johnson Johnson Receives Approval from European Commission For Acquisition Of Crucell
2011-01-31 00:00:00,Johnson Johnson Announces Recall of DePuy Hip Lewitt Hackman Files Suit
2011-02-16 00:00:00,Johnson Johnson Recalls Invega
2011-02-17 00:00:00,Johnson Johnson And Crucell Announce Minimum Acceptance Condition Satisfied
2011-02-22 00:00:00,Johnson Johnson Completes Tender Offer For Crucell And Declares Offer Unconditional
2011-02-24 00:00:00,Abbott Boston Scientific Corporations Boston Scientific Ceska Johnson Medtronic Czechia and Others Win Daily News
2011-03-11 00:00:00,FDA To Oversee Johnson Johnson Plants After Flood Of
2011-03-14 00:00:00,Eli Lilly and Elanco Announces Offer To Acquire Janssen Pharmaceutica Janssen Animal Health Business
2011-03-23 00:00:00,POZEN Announces Licensing Deal with Johnson Cilag GmbH for MT Migraine Treatment
2011-03-24 00:00:00,Johnson Johnson Unit Recalls Surgical Drain
2011-03-29 00:00:00,Johnson Johnson Issues More Drug
2011-03-31 00:00:00,Johnson Johnson Reorganizes Consumer Group In Wake Of
2011-05-20 00:00:00,US FDA Approves New Johnson Johnson HIV
2011-05-23 00:00:00,Johnson Johnson Acquires Russian OTC Medicines For
2011-05-24 00:00:00,JB Chemicals Pharmaceuticals Limited To Sell Business And Worldwide Rights And Registrations Of Three OTC Brands To Johnson Cilag GmbH International
2011-06-24 00:00:00,US FDA urges caution on And Johnson Johnson Anemia
2011-06-28 00:00:00,Gilead And Johnson Tibotec Unit To Develop Combination HIV
2011-07-19 00:00:00,FDA Panel To Consider Additional Use For Johnson Remicade In Pediatric
2011-08-10 00:00:00,Johnson Johnson Reaches Agreement In Principle With The Justice Department To Plead Guilty To A Misdemeanor Violation Of A Federal
2011-09-14 00:00:00,Johnson Johnson Pleads Guilty In Natrecor Marketing
2011-09-23 00:00:00,Bayer AG And Johnson Xarelto Recommended for Approval in the Prevention of AF Related Stroke and Treatment of Deep Vein Thrombosis in EU
2011-09-28 00:00:00,Boston Scientific Did Not Infringe Johnson Unit US Court Upholds Blood Vessel Stent
2011-11-09 00:00:00,Affymax Inc and Johnson Janssen Biotech Settles Patent Dispute
2011-11-17 00:00:00,Johnson Johnson To Nix Baby Product Contaminant Within Two
2012-01-20 00:00:00,Johnson Johnson To Pay Million To Settle Texas Risperdal
2012-01-23 00:00:00,Federal Court Rules In Favor Of Boston Scientific in Johnson Johnson
2012-01-24 00:00:00,Johnson Johnson Issues FY 2012 EPS Guidance Below Estimates
2012-02-08 00:00:00,FDA Says Ulcer Drugs Such As AstraZeneca Nexium May Raise Diarrhea Other Proton Pump Inhibitors Includes Johnson Johnson and Eisai Co
2012-02-21 00:00:00,Alex Gorsky To Succeed Bill Weldon As CEO Of Johnson Johnson
2012-04-11 00:00:00,Johnson Johnson Hit With Billion Risperdal Penalty In
2012-04-17 00:00:00,Johnson Johnson Raises FY 2012 EPS Guidance
2012-04-19 00:00:00,EU Clears Johnson Billion Acquisition Of Synthes
2012-05-16 00:00:00,Johnson Johnson Shows Promise In High Risk Prostate
2012-05-24 00:00:00,US Advisers Reject Johnson Xarelto For Acute Coronary
2012-06-05 00:00:00,Law Office of Brodsky LLC Investigates Potential Claims Against Johnson DePuy Orthopedics
2012-07-24 00:00:00,Pfizer Johnson Johnson Drug Fails One Of Four Big Reuters
2012-08-21 00:00:00,Johnson Unit Recalls Bone
2012-08-30 00:00:00,Johnson Janssen Announces Global License And Development Agreement For Investigational Agent Daratumumab With Genmab
2012-09-04 00:00:00,Johnson Johnson Announces Indirect Stake in Galapagos NV
2012-10-09 00:00:00,Sell Johnson Says Goldman
2012-10-15 00:00:00,Earnings Johnson Johnson Analyst Blog
